IQV · Company research
IQVIA Holdings Inc. (IQV): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
27records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? | IQVIA Holdings is expected to report Q3 2026 earnings on October 27, with consensus estimates of $3.24 EPS (up 8% YoY) and $4.36B in revenues (up 6.4% YoY). However, recent analyst revisions have turned slightly bearish, resulting in a negative Earnings ESP of -0.09%, making it difficult to predict an earnings beat despite the company's strong historical track record of beating estimates in the last four quarters. | View source ↗ | Zacks Investment Research | Oct 20, 2026 | neutral | 0 | 1 |
| IQVIA Holdings Inc. Common Stock (IQV) Company Profile - Pluang | IQVIA Holdings Inc. Common Stock (IQV) Company Profile Pluang | View source ↗ | Pluang | Oct 16, 2026 | neutral | 0 | 0.6 |
| IQVIA Holdings Inc (IQV) Stock Up 3.5% but GF Value Says Overval - GuruFocus | IQVIA Holdings Inc (IQV) Stock Up 3.5% but GF Value Says Overval GuruFocus | View source ↗ | GuruFocus | Oct 15, 2026 | neutral | 0 | 0.6 |
| IQVIA Holdings (NYSE:IQV) Stock Price - Simply Wall Street | IQVIA Holdings (NYSE:IQV) Stock Price Simply Wall Street | View source ↗ | Simply Wall Street | Oct 15, 2026 | neutral | 0 | 0.6 |
| VEEV Expands IQVIA Partnership With Clinical Operations Software Suite | Veeva Systems expanded its partnership with IQVIA, with IQVIA selecting additional Veeva clinical operations applications as enterprise standards for clinical development studies. The agreement covers CTMS, eTMF, Study Startup, and Site Connect tools, building on their previous EDC partnership. This expansion is expected to strengthen Veeva's presence in clinical research, improve trial efficiency, and create cross-selling opportunities, though financial terms and deployment timelines were not disclosed. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bullish | 0.5 | 1 |
| VEEV Expands IQVIA Partnership With Clinical Operations Software Suite | Veeva Systems expanded its partnership with IQVIA, with IQVIA selecting additional Veeva clinical operations applications as enterprise standards for clinical development studies. The agreement covers CTMS, eTMF, Study Startup, and Site Connect tools, building on their previous EDC partnership. This expansion is expected to strengthen Veeva's presence in clinical research, improve trial efficiency, and create cross-selling opportunities, though financial terms and deployment timelines were not disclosed. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bullish | 0.5 | 1 |
| Four Veeva tools will be standard across IQVIA's clinical studies - Stock Titan | Four Veeva tools will be standard across IQVIA's clinical studies Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Why (IQV) Price Action Is Critical for Tactical Trading - Stock Traders Daily | Why (IQV) Price Action Is Critical for Tactical Trading Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 12, 2026 | neutral | 0 | 0.6 |
| IQVIA (IQV) Stock May Be 27% Undervalued Despite Explorer Launch - Simply Wall Street | IQVIA (IQV) Stock May Be 27% Undervalued Despite Explorer Launch Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| IQV Stock Technical Analysis - Pluang | IQV Stock Technical Analysis Pluang | View source ↗ | Pluang | Oct 11, 2026 | neutral | 0 | 0.6 |
| IQVIA Holdings Inc. Common Stock (IQV) Stock Price Today: $259.88 - Pluang | IQVIA Holdings Inc. Common Stock (IQV) Stock Price Today: $259.88 Pluang | View source ↗ | Pluang | Oct 10, 2026 | neutral | 0 | 0.6 |
| Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock | IQVIA Holdings (IQV), a clinical research and healthcare intelligence provider, is highlighted as a stock to watch with a Zacks Rank #3 (Hold) and VGM Score of B. The company has a Momentum Style Score of B with shares up 0.4% over the past four weeks. One analyst revised earnings estimates upward for fiscal 2026, with the Zacks Consensus Estimate at $12.92 per share and an average earnings surprise of +2.2%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock | IQVIA Holdings (IQV), a clinical research and healthcare intelligence provider, is highlighted as a stock to watch with a Zacks Rank #3 (Hold) and VGM Score of B. The company has a Momentum Style Score of B with shares up 0.4% over the past four weeks. One analyst revised earnings estimates upward for fiscal 2026, with the Zacks Consensus Estimate at $12.92 per share and an average earnings surprise of +2.2%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock | IQVIA Holdings (IQV), a clinical research and healthcare intelligence provider, is highlighted as a stock to watch with a Zacks Rank #3 (Hold) and VGM Score of B. The company has a Momentum Style Score of B with shares up 0.4% over the past four weeks. One analyst revised earnings estimates upward for fiscal 2026, with the Zacks Consensus Estimate at $12.92 per share and an average earnings surprise of +2.2%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Across 50 trials, 85% of IQVIA's predictions were on target or close. - Stock Titan | Across 50 trials, 85% of IQVIA's predictions were on target or close. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity | IQVIA reported Q2 2026 adjusted EPS of $3.15, up 12.1% YoY and beating consensus by 4.3%, with revenues of $4.37B up 8.7% and exceeding estimates. R&D Solutions new bookings surged 19% to $3.2B. However, the company faces liquidity concerns with a current ratio of 0.71 and net leverage at 3.6X adjusted EBITDA. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 0.333 | 1 |
| Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity | IQVIA reported Q2 2026 adjusted EPS of $3.15, up 12.1% YoY and beating consensus by 4.3%, with revenues of $4.37B up 8.7% and exceeding estimates. R&D Solutions new bookings surged 19% to $3.2B. However, the company faces liquidity concerns with a current ratio of 0.71 and net leverage at 3.6X adjusted EBITDA. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | bullish | 0.333 | 1 |
| Why IQVIA Holdings (IQV) Stock Is Down Today - Quiver Quantitative | Why IQVIA Holdings (IQV) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 1, 2026 | neutral | 0 | 0.6 |
| Why IQVIA Holdings (IQV) Stock Is Down Today - Moomoo | Why IQVIA Holdings (IQV) Stock Is Down Today Moomoo | View source ↗ | Moomoo | Oct 1, 2026 | neutral | 0 | 0.6 |
| IQVIA Holdings (IQV) Prices $2b Notes, Does The Stock Look Fairly Valued? - Yahoo Finance | IQVIA Holdings (IQV) Prices $2b Notes, Does The Stock Look Fairly Valued? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 19, 2026 | neutral | 0 | 0.6 |
| IQVIA (IQV) Stock Could Be Undervalued After Its 42% Run - Yahoo Finance | IQVIA (IQV) Stock Could Be Undervalued After Its 42% Run Yahoo Finance | View source ↗ | Yahoo Finance | Sep 19, 2026 | neutral | 0 | 0.6 |
| IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know - Yahoo Finance | IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Sep 16, 2026 | neutral | 0 | 0.6 |
| Why IQVIA Holdings (IQV) Stock Is Up Today - Quiver Quantitative | Why IQVIA Holdings (IQV) Stock Is Up Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 20, 2026 | neutral | 0 | 0.6 |
| IQVIA Stock Climbs 25% On A 5-Day Winning Streak - Trefis | IQVIA Stock Climbs 25% On A 5-Day Winning Streak Trefis | View source ↗ | Trefis | Jul 30, 2026 | neutral | 0 | 0.6 |
| Why Is IQVIA (IQV) Stock Soaring Today - StockStory | Why Is IQVIA (IQV) Stock Soaring Today StockStory | View source ↗ | StockStory | Jul 1, 2026 | neutral | 0 | 0.6 |
| Why Is IQVIA (IQV) Stock Soaring Today - StockStory | Why Is IQVIA (IQV) Stock Soaring Today StockStory | View source ↗ | StockStory | May 5, 2026 | neutral | 0 | 0.6 |
| IQV Stock Price and Chart — NYSE:IQV - TradingView | IQV Stock Price and Chart — NYSE:IQV TradingView | View source ↗ | TradingView | Jan 28, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.